Li‐Jiao Tian
Papers
1
Total Citations
11
H-Index
1
About
Li‐Jiao Tian is pioneering the intersection of synthetic biology and nanomedicine, with a core focus on biohybrid systems for targeted cancer therapy. Her most notable contribution is the development of self-mineralized biohybrid robots, exemplified by the SO@FeS system, which leverages the facultative anaerobic bacterium *Shewanella oneidensis* to synergize apoptosis and ferroptosis for tumor-selective treatment. In her landmark 2025 study, Tian achieved the first direct visualization of this therapeutic synergy using cryo-soft X-ray tomography, providing unprecedented nanoscale insight into the biohybrid’s mechanism of action. This work, already garnering 11 citations, demonstrates her ability to merge cutting-edge imaging with innovative therapeutic design. Tian’s research addresses a critical challenge in oncology: achieving precise, synergistic tumor killing while minimizing off-target effects. Her biohybrid approach, which harnesses the natural tumor-homing and mineralization capabilities of bacteria, represents a paradigm shift from conventional nanoparticle-based therapies. By integrating living organisms with inorganic nanomaterials, she is advancing a new class of "living therapeutics" that could redefine cancer treatment. For students and researchers, Tian’s work exemplifies how interdisciplinary thinking—bridging microbiology, materials science, and bioimaging—can yield transformative solutions in biomedicine.
Research Focus
Key Achievements
Top Papers
- 1